Study unveils a potential solution to combat age-related immune system decline

As we age, our bodies face numerous challenges, including a decline in immune system function and an increased vulnerability to various health issues.

BMS reports 2% revenue loss in 2023 after Revlimid generics hurt sales – Pharmaceutical Technology

Share this article Bristol Myers Squibb’s French headquarters in Rueil-Malmaison, France. Credit: HJBC via Shutterstock. BMS has reported its results for the 2023 financial year

February 2, 2024

Merck drug for rare, deadly lung condition appears set for approval in U.S.

The Food and Drug Administration is expected to approve Merck’s drug to treat a rare lung disorder called pulmonary arterial hypertension on Tuesday, making available

March 26, 2024

Partnerships are key to driving digital healthcare transformation in US, say experts – Pharmaceutical Technology

Share this article Credit: Shutterstock Partnerships between different stakeholders in the healthcare industry are crucial for driving healthcare transformation. Stakeholders can include diverse groups –

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.